RIVERNORTH CAPITAL MANAGEMENT, LLC - CARDIO DIAGNOSTICS HOLDGS IN ownership

Back to all holdings Add to watchlist

CARDIO DIAGNOSTICS HOLDGS IN's ticker is and the CUSIP is 14159C111. A total of 22 filers reported holding CARDIO DIAGNOSTICS HOLDGS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
RIVERNORTH CAPITAL MANAGEMENT, LLC ownership history of CARDIO DIAGNOSTICS HOLDGS IN
ValueSharesWeighting
Q3 2023$1,964
-78.9%
49,0990.0%0.00%–
Q2 2023$9,329
-41.7%
49,099
-1.8%
0.00%
-100.0%
Q1 2023$16,000
+540.0%
49,9990.0%0.00%–
Q4 2022$2,500–49,999–0.00%–
 Download
Other shareholders
CARDIO DIAGNOSTICS HOLDGS IN shareholders Q4 2022
NameSharesValueWeighting ↓
EHP Funds Inc. 364,492$180.00%
BOOTHBAY FUND MANAGEMENT, LLC 100,000$106,0000.00%
Radcliffe Capital Management, L.P. 50,000$53,0000.00%
K2 PRINCIPAL FUND, L.P. 92,500$4,5790.00%
ATW SPAC MANAGEMENT LLC 100,000$4,9500.00%
Yakira Capital Management, Inc. 69,499$3,4400.00%
Walleye Trading LLC 24,139$1,1950.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,483$6180.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 49,999$2,5000.00%
HRT FINANCIAL LP 36,200$10.00%
View complete list of CARDIO DIAGNOSTICS HOLDGS IN shareholders